Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-01-11 @ 3:37 AM
Study NCT ID:
NCT05972967
Status:
COMPLETED
Last Update Posted:
2025-10-01
First Post:
2023-07-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab
Sponsor:
Omeros Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OMS906-PNH-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None